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The present study demonstrates the antibacterial potential of a phage endolysin
against Gram-negative pathogens, particularly against multidrug resistant strains of
Acinetobacter baumannii. We have cloned, heterologously expressed and characterized
a novel endolysin (ABgp46) from Acinetobacter phage vb_AbaP_CEB1 and tested
its antibacterial activity against several multidrug-resistant A. baumannii strains. LC-
MS revealed that ABgp46 is an N-acetylmuramidase, that is also active over a broad
pH range (4.0–10.0) and temperatures up to 50◦C. Interestingly, ABgp46 has intrinsic
and specific anti-A. baumannii activity, reducing multidrug resistant strains by up to 2
logs within 2 h. By combining ABgp46 with several organic acids that act as outer
membrane permeabilizing agents, it is possible to increase and broaden antibacterial
activity to include other Gram-negative bacterial pathogens. In the presence of citric and
malic acid, ABgp46 reduces A. baumannii below the detection limit (>5 log) and more
than 4 logs Pseudomonas aeruginosa and Salmonella typhimurium strains. Overall, this
globular endolysin exhibits a broad and high activity against Gram-negative pathogens,
that can be enhanced in presence of citric and malic acid, and be used in human and
veterinary medicine.
Keywords: Acinetobacter baumannii, phage endolysins, mass spectrometry, circular dichroism, antibacterial
activity
INTRODUCTION
Gram-negative (G−) pathogenic bacteria remain a global human health concern as they are
common causes of foodborne, environmentally acquired, and zoonotic infectious diseases (Chopra
et al., 2008; Scallan et al., 2011). This problem is exacerbated by their ability to display intrinsic
[e.g., low outer membrane (OM) permeability] or acquired antibiotic resistant mechanisms (e.g.,
horizontal transfer of resistance genes; Bonomo and Szabo, 2006). Acinetobacter baumannii and
Pseudomonas aeruginosa cause a wide range of nosocomial diseases (including wound, skin
infections) and are characteristic strains for which resistance has occurred against and spread to
nearly all antibiotics available. The development and spread of multidrug resistant pathogens have
instigated and intensified the interest in alternative antimicrobials.
Bacteriophage (phages) lytic enzymes, called endolysins, are proteins synthesized at the end
of the phage lytic cycle to destroy the cell wall peptidoglycan (PG) to release viral progeny
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(Fischetti, 2005). Endolysins have either a single catalytic
domain (globular structure) responsible for the PG digestion by
glycosidase, amidase or peptidase activity, typically observed in
phages infecting G− hosts, but can contain a second domain
[modular structure, an architecture more prominent in Gram-
positive (G+)-like endolysins] that aids substrate recognition and
binding (Oliveira et al., 2012). Recent in silico analysis illustrated
the large diversity and complexity of endolysins that can comprise
up to four domains in the same coding sequence, have 24 different
types of catalytic and 15 binding domains, and 89 possible
architectural organizations (Oliveira et al., 2013). In view of this
tremendous diversity, endolysins have received relatively little
attention, especially in terms of more fundamental aspects such
as their conformation analysis as well as their its anti-G− activity.
Due to their biotechnological potential of endolysins including
their unique ability to rapidly cleave the bacterial PG through
external application and the absence of reported resistance
development, endolysins have sparked the interest as alternatives
for existing antibiotics (Nelson et al., 2001). However, a
review of the literature still demonstrates an overwhelming and
almost exclusive application of endolysins in combating G+
pathogens (Fischetti, 2010). This has been shown, for example,
on methicillin-resistant and multidrug-resistant Staphylococcus
aureus (endolysins LysK and MV-L, respectively; O’Flaherty et al.,
2005; Rashel et al., 2007), on vancomycin-resistant Enterococcus
faecalis and E. faecium (endolysin PlyV12; Yoong et al., 2004).
The limited number of publications against G− bacteria is
explained by permeabilization issues due to the presence of the
OM that hinders the action of externally added endolysins (Vaara,
1999). To date, only a few endolysins were successfully reported
to kill G− cells (Lood et al., 2015), mostly combining endolysin
activity with the chelating effect of EDTA to permeabilize the OM
and, more recently, by novel engineering strategies, for specific
applications (Lim et al., 2012; Walmagh et al., 2012; Briers et al.,
2014a,b; Lood et al., 2015). Recently, the application of endolysins
in combination with weak acids (citric and malic acid), also
proved to be successful in eliminating a broad range of G−
pathogens (Oliveira et al., 2014).
This study describes the isolation of a phage-encoded
endolysin (ABgp46) originating from an Acinetobacter phage
vb_AbaP_CEB1. ABgp46 was fully characterized in terms of
its primary, secondary and tertiary structure under different
physiological conditions giving novel insights into this class
of proteins. Its antibacterial action was studied by combining
the endolysin with several organic acids (citric, malic, lactic,
benzoic, and acetic acid) against antibiotic resistant G− bacteria.
This work demonstrates that weak acids are suitable OM
permeabilizers (OMPs), enabling ABgp46 to reach the PG and
kill the cells.
MATERIALS AND METHODS
Bacterial Strains, Media, and Chemicals
Bacterial strains were acquired either from the American Type
Culture Collection (S. typhimurium ATCC 19585, P. aeruginosa
ATCC 15692, and Klebsiella oxytoca ATCC 131821) or from
the Spanish Type Culture Collection (Escherichia coli O157:H7
CECT 47821). Clinical Acinetobacter isolates are multi-resistant
and were kindly provided by the Hospital of Braga with
patterns of antibiotic resistance given for each strain. All
strains were grown in Lysogeny Broth (LB; Liofilchem) at
37◦C and 120 rpm. For transformation, chemically competent
E. coli TOP10 and E. coli BL21(DE3) cells (Invitrogen) were
prepared for cloning and recombinant protein expression
respectively. The Acinetobacter phage vb_AbaP_CEB1 (encoding
the ABgp46 endolysin) was isolated from waste eﬄuents and
belongs to the Centre of Biological Engineering phage collection
(Braga, Portugal). This phage belongs to the Podoviridae
family and is a T7 likeviruses EDTA was acquired from
Pronalab while isopropyl-β-D-thiogalactopyranoside (IPTG),
HEPES and the organic acids were purchased from Sigma-
Aldrich.
Cloning, Recombinant Protein
Expression, and Purification
Phage DNA was extracted from concentrated purified phage
lysates using the phenol:chloroform extraction method
(Sambrook et al., 2001). Afterward, the ABgp46 ORF was
amplified from the phage genomic DNA using Phusion High-
Fidelity DNA Polymerase (NEB) and a set of specific primers
(forward: 5-GGCAGCCATATGATTCTGACTAAAGACGGGT
TTAG and reverse: 5-GCAGCCGGATCCCTATAAGCTCCGTA
GAGCGC, with the NdeI/BamHI restriction endonuclease sites
underlined). Next, the amplicon was purified (DNA Clean &
Concentrator-5k, Zymo Research), digested using NdeI and
BamHI enzymes (NEB), and cloned in the pET15b expression
vector (Novagen) with an N-terminal His6-tag. The insert
was confirmed by Sanger sequencing (Eurofins). The sequence
of ABgp46 was deposited in GenBank under accession no.
KP998152.
Escherichia coli BL21(DE3) was transformed with the pET15b-
ABgp46 vector and the endolysin produced as follows: cells
were grown in 200 mL LB (supplemented with 100 µg/mL of
ampicillin) to an OD600 nm of 0.6 (approximately 4 h, 120 rpm
at 37◦C; ES-20/60), and recombinant protein expression induced
with 0.5 mM IPTG at 16◦C, 120 rpm overnight. The culture was
then centrifuged (9500 × g, 30 min), and the cells disrupted by
suspending the pellet in 1/25 volumes of lysis buffer (20 mM
NaH2PO4, 0.5 M NaCl/NaOH, pH 7.4), followed by three cycles
of freeze-thawing (−80◦C to room temperature). Maintaining
the sample on ice, cells were further disrupted by sonication
(Cole-Parmer, Ultrasonic Processors) for 8–10 cycles (30 s pulse,
30 s pause). Insoluble cell debris was removed by centrifugation
(9500 × g, 30 min, 4◦C) and the supernatant was collected,
filtered (0.22 µm filters, GE Healthcare) and applied to Ni2+-
NTA resin stacked in HisTrapTM HP 1 mL columns (GE
Healthcare) for purification, using a imidazole gradient (25–
300 mM). Eluted protein fractions were visualized by standard
denaturation SDS-PAGE gels, and only protein fractions with
purity >95% were dialyzed in 10 mM PBS at pH 7.2 (using
Maxi GeBAflex-tube Dialysis Kit – Gene Bio-Application Ltd).
The protein was quantified using the BCA TM Protein Assay Kit
(Thermo Scientific).
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Endolysin Activity Characterization
Detection and Quantification of Muralytic Activity
The assessment of the ABgp46 muralytic (PG degrading) activity
was performed by visualizing inhibition spots on G− bacteria
lawns, as described elsewhere (Schuch et al., 2009). Briefly,
100 µL of Acinetobacter strains grown to an OD600 nm of 0.6
were spread over the surface of LB agar and grown overnight
at 37◦C. Formed bacterial lawns were subsequently treated with
chloroform vapors for 30 min to induce OM permeabilization,
after which a 30-µL drop of purified ABgp46 was spotted. After
a few minutes, the visualization of inhibition halos determined
the presence of a endolysin activity, for its ability to degrade the
exposed PG.
The muralytic activity of ABgp46 was quantified on
permeabilized P. aeruginosa cells following treatment with
chloroform/Tris-HCl to allow the protein to reach its PG
substrate (Lavigne et al., 2004). Briefly, mid-exponential
P. aeruginosa strains were centrifuged (4600× g, 30 min at 4◦C),
suspended in the upper layer of chloroform-saturated 50 mM
Tris-HCl, pH 7.7 solution and incubated for 45 min at 120 rpm.
Following incubation, bacterial protoplasts were collected
(4000 × g, 15 min, 4◦C), washed and suspended in 80 mM of
KH2PO4/K2HPO4 buffer (pH 7.2) then adjusted to an OD600 nm
of 1.2. Bacterial protoplasts were stored at −20◦C prior to use.
To measure enzymatic activity, 30 µL of enzyme (0.125, 0.25,
0.5, 1, 2, 4, and 8 µM) were added to 270 µL of permeabilized
P. aeruginosa cells. The resulting decrease in optical density
was measured spectrophotometrically (BIO-TEK R©, Synergy
HT Microplate Reader) for up to 30 min of reaction with
readings taken every 30 s. To measure the pH dependence,
chloroform/Tris-HCl permeabilized OM P. aeruginosa cells
were suspended in a universal pH buffer (10 mM KH2PO4,
10 mM Na-citrate and 10 mM H3BO4), with a pH adjusted
between 4.0 and 10.0. Obtained OD values were adjusted for the
contribution of the negative control (PBS treated). The muralytic
activity was calculated based on the best linear regression of
the saturation curve and expressed in units/µM according to
a validated method explained in detail elsewhere (Briers et al.,
2007).
Stability
The enzyme stability was tested using similar turbidity tests
as described previously (Oliveira et al., 2014). Enzyme kinetics
experiments were performed using 2 µM of ABgp46 stored
at 4◦C for 2 months, or heated at different temperatures of
20, 30, 40, 50, and 60◦C for 30 min in a MJ Mini BIO-RAD
Thermocycler, in the universal buffer at optimal pH. The residual
muralytic activity of each sample relative to the activity of
the unheated reference sample at time 0 (=100% activity) was
determined.
Determination of the PG Cleavage Site
The ABgp46 cleavage site was determined using E. coli BW25113
1lpp PG sacculi as a substrate. PG was extracted from
exponentially growing E. coli cells as previously described using
boiling SDS (Glauner, 1988). Five hundred µg of pure PG
was digested overnight with 0.6 mg/ml of ABgp46 at 37◦C
in 25 mM of phosphate buffer pH 6.0, supplemented with
0.1 mM of MgCl2 in a final volume of 100 µl. E. faecalis
AtlA N-acetylglucosaminidase (0.6 mg/ml) and S. globisporus
N-acetylmuramidase mutanolysin (Sigma-Aldrich; 500 µg/ml)
were used as controls to digest 500 µg of E. coli PG in
25 mM Tris-HCl (pH 8.0) and 25 mM of phosphate buffer
(pH 6.0), respectively. Soluble muropeptides were recovered by
centrifugation (20,000× g, 15 min, 20◦C), reduced with 5 mg/ml
of sodium borohydride and separated by reverse-phase HPLC
(RP-HPLC) on a Hypersil aQ C18 column (3 µm; 2.1 by 200 mm;
ThermoFisher Scientific) connected to an Agilent 6500 Series
Q-TOF LC/MS System. Muropeptides were eluted at a flow rate
of 0.25 ml/min with a 0 to 15% gradient applied between 6 and
40 min [Buffer A, 0.1% (v/v) formic acid in water; buffer B, 0.1%
(v/v) formic acid in acetonitrile].
Endolysin Conformation Stability
Fluorescence measurements
The intrinsic fluorescence emission spectrum of the ABgp46
was measured over the 300–400 nm range using a Jasco FP-
750 spectrofluorimeter equipped with a Peltier thermostat. An
excitation wavelength of 295 nm was used to minimize the
emission arising from tyrosine residues. Thermal denaturation
was monitored by heating 2 µM protein in universal buffer
with a constant rate of 2◦C/min from 20 to 70◦C. The variation
of the fluorescence spectra was measured as a variation of
Parameter A defined as the ratio of intensity of fluorescence (IF)
at 360 and 325 nm (IF 360/IF 325). Parameter A was plotted
as a function of temperature and fitted in Boltzmann sigmoidal
curves.
Circular dichroism analysis
Endolysin circular dichroism (CD) spectra were recorded in
triplicate in the Far-UV region (195–260 nm) using a J-1100
CD Spectrometer, Jasco, in the universal buffer (pH 4.0–10.0).
Spectra were recorded at desired pH, from 20 to 70◦C, with a
thermal increase rate of 2◦C/min. All CD spectra were baseline
corrected and smoothed with the Spectra Analysis JASCO
software. The intensity of the CD signal measured at 222 nm
was plotted as a function of temperature and fitted in Boltzmann
sigmoidal curves. In all cases, an enzyme concentration of
8 µM (0.18 mg/mL) and an optical path of 0.1 cm were
used.
Antibacterial Assays
In vitro assays on planktonic cells were performed as described
previously (Oliveira et al., 2014), with minor modifications.
Mid-exponential phase cells (OD600 nm of 0.6) suspended and
100-fold diluted in 10 mM HEPES/NaOH (pH 7.2), were
prepared. Each culture (50 µL) was incubated for 2 h at room
temperature with 25 µL of ABgp46 (final concentration of
2 µM) together with 25 µL of water or 25 µL or OMPs
(EDTA, citric, malic, lactic, benzoic, or acetic acid) dissolved in
water. Parallel experiments were also carried out supplementing
the reaction with 5 mM of MgCl2 to evaluate the effect of
free divalent cations in the solution. In all cases, negative
controls were included by incubating 50 µL of cells with
25 µL of PBS (pH 7.2; replacing ABgp46) or with 25 µL
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water (instead of OMPs). After incubation, CFUs were counted
in LB agar plates and the antibacterial activity quantified as
the relative inactivation in logarithmic units [= log10 (N0/Ni)
with N0 = number of untreated cells (in the negative control)
and Ni = number of treated cells counted after incubation].
Averages ± standard deviations for all experiments are given for
n= 4 repeats.
RESULTS
In silico Analysis of the Primary Structure
Acinetobacter phage vB_AbaP_CEB1 was previously isolated
and sequenced (unpublished data). ORF 46 (referred to as
ABgp46), encoding a 185-amino acid protein with a deduced
molecular mass of 23.1 kDa, is predicted to act as a PG hydrolase
with a HHpred output showing that ABgp46 belongs to the
CAZY glycosidase family 19 (GH19; E-value = 2 × 10−36;
Cantarel et al., 2009). GH19 represents a class of chitinases
that cleaves the unbranched chains of N-acetyl glucosamine
polymers, a structure uncommon in bacterial cell walls,
but some enzymes that able to degrade the PG of G−
bacteria have also been shown (e.g., Pseudomonas phage OBP
and Salmonella phage PVP-SE1 endolysins; Walmagh et al.,
2012).
BlastP analyses showed that the protein has a high sequence
similarity to four other predicted endolysins from Acinetobacter
phages (phiAB1, phiAB3, ABP-01, and ABP-04). Amphipathic
helices were identified between the amino acids 112 and
145 (KNPEKALEPLIAIQIAIKGMLNGWFTGVGFRRKR), with
positively charged amino acids shown in bold. The same
sequence has been observed in the A. baumannii phage
endolysin LysAB2, which has been shown to interfere with the
A. baumannii OM (Lai et al., 2011). ABgp46 was produced
as a recombinant protein in E. coli and purified under native
conditions, yielding a soluble protein of 20.5 mg per liter of
culture.
Endolysin Muralytic Activity, pH
Dependence, and Stability
ABgp46 was able to lyse OM compromised A. baumannii #2
lawn(phage host) and its activity calculated using turbidimetry
assays. ABgp46 is active between of pH of 4.0–9.0 with an
optimal between 8.0 and 9.0 (Figure 1A). At optimal pH,
ABgp46 had a muralytic activity of 490 units/µM. In addition,
ABgp46 remained fully active after 1 month at 4◦C with a
25% decrease in activity observed after 30 min incubation at
50◦C and complete inactivation after 30 min incubation at 60◦C
(Figure 1B).
RP-HPLC and LC-MS Analysis of the
Biochemical Activity of ABgp46
The PG bond cleaved by ABgp46 was identified by LC-MS
(Supplementary Figures S1 and S2) using E. coli purified
PG as a substrate. The muropeptide profiles corresponding
to the digestion of E. coli PG by ABgp46, E. faecalis
AtlA (an N-acetylglucosaminidase) and mutanolysin (an
N-acetylmuramidase) were similar, suggesting that ABgp46
displays glycosyl hydrolase activity. MS analysis of the
muropeptides corresponding to the major monomers solubilized
(peaks 1–3 in Supplementary Figure S1) identified ions with
m/z values of 942.415, 942.414, and 942.414, respectively,
matching the theoretical value expected for a disacharride-
tetrapeptide (942.414). To identify whether ABgp46 is an
N-acetylmuramidase or an N-acetylglucosaminidase, we
analyzed the fragmentation pattern of the ions with an
m/z at 942.414 to identify the sugar moiety harboring a
reducing group (Eckert et al., 2006). Major ions in peaks 1
(mutanolysin digestion) and 3 (ABgp46 digestion) both revealed
a fragmentation event leading to the loss of a non-reduced
GlcNAc residue (−203.078 atomic mass units, seen as a [M+H]+
adduct with m/z at 204.086 and 204.087) indicating that
ABgp46 displays N-acetylmuramidase (lysozyme) activity. By
contrast, the major ion in peak 2 (AtlA digestion) revealed a
FIGURE 1 | pH and temperature effect on the ABgp46 activity. (A) The pH dependence was measured as the slope of the OD600 nm/min curve, using
Pseudomonas aeruginosa OM permeabilized cells as a substrate, suspended in a universal buffer (10 mM KH2PO4, 10 mM Na-citrate, and 10 mM H3BO4), and
with pH adjusted from 4.0 to 10.0. (B) The stability was tested by heating the protein at different temperatures (20–60◦C) for 30 min, and using OM permeabilized
P. aeruginosa PAO1 cells at pH of 8.0. The residual activity shown, is expressed in percentage by comparing with ABgp46 stored at 4◦C (=100% relative activity).
Averages and standard deviations of four repeated experiments are shown.
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fragmentation event leading to the loss a reduced GlcNAc residue
(−223.106 atomic mass units, seen as a [M+H]+ adduct with
an m/z at 224.113) expected for an N-acetylglucosaminidase
activity (Supplementary Figure S2). Collectively, these results
demonstrate that ABgp46 displays N-acetylmuramidase
activity.
Conformational Analysis of ABgp46
An analysis of the ABgp46 tertiary and secondary structure was
performed under different pH values, using CD and protein
intrinsic fluorescence, respectively. The fluorescence spectra
of ABgp46 obtained at different pH values are depicted in
Figure 2A. Using the presence of the two tryptophan residues
(Trp-95 and Trp-135) in the sequence, an excitation wavelength
of 295 nm was used, minimizing the contribution of tyrosine
fluorescence. In general, when increasing the temperature from
20 to 70◦C, Parameter A showed a similar trend for all
pH value and a marked variation was observed at 50◦C.
Exceptions were pH 4.0 and 10.0 with a Parameter A variation
at lower temperatures in the range of 45–46◦C. Such spectral
variations can be correlated to folding changes of the tertiary
structure.
Circular dichroism measurements revealed signal minima
around 208 and at 220 nm that prevail in the far-UV CD spectra,
which is indicative of α-helices in this protein. The same CD
spectra were obtained as a function of pH adjusted from 4.0 to
10.0, indicating an unchanged protein secondary structure (data
not shown). To determine the enzyme’s conformational stability
in depth, a thermal treatment was employed by increasing
temperature of the protein solution at different pH values
(Figure 2B). Secondary structure changes were analyzed by
monitoring CD intensity at 222 nm where α-helix structures
show a negative peak. No differences were observed between
pH 5.0–9.0, where all Tm were recorded in the range of 51–
52◦C. Extreme pH values of 4.0 and 10.0 were less favorable
conditions to maintain the secondary structure integrity, with
Tm of 44.7 and 44.4◦C, respectively. Interestingly, the pH 4.0
was the only condition where the protein did not aggregate after
reaching the Tm, i.e., thermal unfolding. Overall, based on the
Parameter A and the ellipticity data, it is likely that tertiary and
secondary structure starts to melt at 40◦C, resulting in unfolded
and denatured protein above 50◦C.
In vitro Antibacterial Activity
The in vitro antibacterial activity of the recombinant ABgp46
was investigated on a wide set of G− strains (Table 1). The
activity of Abgp46 alone on tested cells was insignificant
as expected, with the exception of A. baumannii strains.
Interestingly, some Acinetobacter strains were mildly
sensitive to the endolysin alone, causing between 1 and 2
log reductions of viable cells, including strains resistant to several
antibiotics.
To broaden and increase the antimicrobial effect of the
Abgp46 to other G− pathogens, E. coli O157:H7 CECT
4782 was chosen as a model strain, to test and optimize
an ABgp46/OMP formula. Several organic acids (citric and
malic, lactic, benzoic, and acetic acid) were used to sensitize
the G− to the endolysin by permeabilizing the OM. Each
OMP was used in different concentrations (to achieve three
distinct reaction pH values of 7.0, 5.5, and 4.0) and combined
with ABgp46 to assess the best antibacterial condition after
2 h incubation (illustrated in Table 2). At pH 7.0, only the
ABgp46/citric acid was able to slightly reduce E. coli cells
(0.86 ± 0.28 logs; Table 2). At pH 5.5, the effect was broadened
to ABgp46/citric acid, ABgp46/malic acid and ABgp46/lactic
acid mixtures reducing approximately 1 log of E. coli cells
(Table 2). Consistently, the effect was more pronounced at pH
of 4.0. At this pH, the combinatorial effects of ABgp46/citric
acid, ABgp46/malic acid, and ABgp46/lactic acid mixtures
resulted in 2.78 ± 0.37, 2.08 ± 0.32, and 0.94 ± 0.28
log reductions, respectively (Table 2). In this condition, the
antibacterial effect was also extended to ABgp46/benzoic acid
inactivating approximately 1 log of E. coli cells. No effect
was observed with ABgp46/acetic acid. Taking into account
FIGURE 2 | Variation of ABgp46 tertiary and secondary structure with pH and temperature. (A) Correlation between fluorescence spectra and
conformational changes deduced by plotting Parameter A as a function of the same pH and temperature ranges, for tertiary structure analysis. (B) Far-UV Circular
dichroism thermal denaturation profiles (from 20 to 70◦C, with heating rates of 2◦C/min), measured at 222 nm, and at different pH values (pH 4.0–10.0) for
secondary structure analysis.
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the most efficient conditions tested, ABgp46/OMPs mixtures
(OMPs concentrations used to achieve a pH of 4.0) were tested
in the presence of 5 mM MgCl2. MgCl2 provides an extra
source of available divalent cations (Mg2+) that can link to
the LPS negatively charged phosphate groups, strengthening
the LPS monolayer (Vaara, 1999). Therefore, the addition of
MgCl2 completely abolished the activity of all ABgp46/OMP
combinations.
After optimization, citric (at 3.65 mM) and malic (at
4.55 mM) acids were selected as the best OMPs to be
combined with ABgp46. Their synergistic effect was further
tested on the remaining unsensitized G− strains tested earlier
and compared with the gold standard EDTA (at 0.5 mM)
OMP (Table 3). In the presence of OMPs and ABgp46 no
surviving A. baumannii cells of strain #2 (phage host strain),
could be detected (>5 log reduction; limit of detection,
<10 CFU/ml). In addition, P. aeruginosa and S. typhimurium
showed a greater than 4 log reduction when combined with
citric or malic acid. Lower, yet still significant reductions,
ranging from 1 to 2 logs, were observed against Cronobacter
sakazakii. In case of K. oxytoca, only the ABgp46/citric acid
and ABgp46/malic acid combinations showed a moderate effect
with log reductions of 0.96 ± 0.35 and 0.81 ± 0.12 viable cells,
respectively.
Overall, an antibacterial effect was observed when ABgp46 was
combined with different OMPs, and its effect was found to be
more pronounced in the presence of citric or malic acid than
when the chelating agent EDTA was used.
TABLE 1 | Antibacterial activity of ABgp46 against several Gram-negative
bacterial pathogens.
Bacterial species ABgp46/water Origin/characteristics
P. aeruginosa PAOI 0.03 ± 0.02 Reference strain (ATCC 15692)
S. typhimurium LT2 0.14 ± 0.05 Clinical strain
E. coli 0157:H7 0.17 ± 0.12 Reference strain (CECT 4782)
C. sakazakii 0.23 ± 0.26 Reference strain (CECT 858)
K. oxytoca 0.18 ± 0.13 Reference strain (ATCC 13182)
A. baumannii #1∗ 1.79 ± 0.38 Clinical strain (TI, AMC, TZP, CE, AZ,
ME, AN, GM, NN, CP, PF, TS)
A. baumannii #2∗ 0.93 ± 0.25 Clinical strain (TI, AMC, TZP, CE, AZ,
ME, AN, GM, NN, CP, PF, TS)
A. baumannii #3∗ 1.00 ± 0.32 Clinical strain (TI, AMC, TZP, CE, CEF,
AZ, ME, GM, NN, CP, PF, TS)
A. baumannii #4∗ 0.81 ± 0.21 Clinical strain (TI, AMC, TZP, CE, CEF,
AZ, ME, GM, NN, CP, PF, TS)
A. baumannii #5∗ 0.37 ± 0.19 Clinical strain (TI, AMC, TZP, CE, CEF,
AZ, ME, CP, PF)
A. baumannii #6∗ 1.20 ± 0.46 Clinical strain (TI, AMC, TZP, CE, CEF,
AZ, ME, CP, PF)
Averages ± standard deviations for all experiments are given for n = 4 repeats.
Marked in bold are ≥1 log reduction units observed. ∗Known patterns of
antibiotic resistance provided by the Hospital of Braga, based on susceptibility
tests performed according to the NCCLS for antibiotic resistance; TI, Ticarcillin;
AMC, amoxicillin/clavulanic acid; TZP, piperacillin/tazobactam; CE, ceftazidime CEF,
Cefepime; AZ, Aztreonam, ME, meropenem; AN, amikacin; GM, gentamicin; NN,
tobramycin; CP, ciprofloxacin; PF, Pefloxacin; TS, Trimethoprim/Sulfametoxazol.
DISCUSSION
G− bacterial infections have always been a threat to human
health. In particular, infections caused by antibiotic resistant
bacteria are problematic and their incidence is constantly
reported worldwide (Chopra et al., 2008; Scallan et al., 2011).
Phage-encoded endolysins represent one promising avenue of
investigation to fight these pathogens.
Biochemical characterization assays were carried out with
ABgp46 to expand the knowledge of the G−-like endolysins
activity and their conformational stability. LC-MS experiments
demonstrated that ABgp46 is an N-acetylmuramidase,
cleaving the PG between MurNAc and GlcNAc glycan strands.
Compared to previously reported G−-like globular endolysins
(Supplementary Table S1), ABgp46 has a similar muralytic
activity, and is more active at alkaline conditions (pH 8.0–9.0; Lai
et al., 2011; Walmagh et al., 2013). Like others (Supplementary
Table S1), ABgp46 also retains its activity once refrigerated for
at least 1 month, and only few endolysins are regarded as heat-
resistant proteins (Walmagh et al., 2012, 2013). The biochemical
characterisation of the endolysin was also complemented by
analyzing the stability of its structure. In this study, we employed
fluorescence and CD studies that indicated that ABgp46 has
a melting temperature of 52◦C, at the optimal pH value. The
good correlation between muralytic activity and conformational
changes as a function of temperature strongly suggests that the
decrease of activity observed for ABgp46 above 50◦C is mainly
due to structural protein modifications. Similar studies have only
been conducted with a Salmonella phage endolysin Lys68, with
an observed melting temperature of 44◦C (Oliveira et al., 2014).
To evaluate the potential use of ABgp46 as an antimicrobial
compound, the enzyme was first tested without the addition of
a permeabilizer. Interestingly, despite the present of the OM
protecting the PG layer, externally added ABgp46 was active
against several multi-resistant Acinetobacter strains (14 out of 17
antibiotics). This is a rare event reported for G−-like endolysins.
The T4 lysozyme (from the T4 phage), was the first endolysin
described to naturally kill G− cells. It was shown that its
C-terminal positively charged amphipathic α-helix (named α-
4) is responsible to cause OM disruption, having a stronger
bactericidal effect than the enzymatic PG hydrolysis (During
et al., 1999). Later, four other endolysins (OBPgp279, Lys1521,
PlyF307, and LysAB2) were also reported to spontaneously
inactivate G− cells (Morita et al., 2001; Lai et al., 2011; Walmagh
et al., 2012; Lood et al., 2015). However, opposite to the
bactericidal effect of synthetic α-4 of T4 lysozyme, it is assumed
that the C-terminal positively charged region of these endolysins
does not have an antibacterial effect per se, but rather mediate
the N-terminal enzymatic domain to enter the cells, allowing
them to digest the PG and cause bacteriolysis. In general, these
endolysins capable of spontaneously killing G− bacteria show
a very specific antibacterial activity. This intrinsic antibacterial
activity that was also observed for ABgp46 can be explained by
the same C-terminal amphipathic region (amino acid sequence
between 112 and 145) identified in LysAB2.
To improve the antibacterial activity, ABgp46 was combined
with concentrations of OMP agents (citric, malic, lactic, benzoic,
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TABLE 2 | Combinatorial antibacterial activity of ABgp46 with outer membrane permeabilizers under different concentrations against Escherichia coli
O157:H7.
pH OMPs Molarity (mM) PBS/OMPs ABgp46/OMPs ABgp46/OMPs
+ 5 mM MgCI2
7.0 ± 0.1 EDTA 0.50 0.27 ± 0.11 0.32 ± 0.15
Citric 0.36 0.21 ± 0.14 0.86 ± 0.28
Malic 0.60 0.24 ± 0.11 0.53 ± 0.28
Lactic 1.20 0.24 ± 0.14 0.55 ± 0.31
Benzoic 1.20 0.26 ± 0.15 0.49 ± 0.34
Acetic 1.20 0.25 ± 0.14 0.53 ± 0.30
5.5 ± 0.1 Citric 1.50 0.20 ± 0.13 1.45 ± 0.25
Malic 3.30 0.17 ± 0.14 1.09 ± 0.29
Lactic 3.45 0.31 ± 0.07 0.95 ± 0.14 -
Benzoic 3.55 0.27 ± 0.13 0.44 ± 0.33
Acetic 4.35 0.26 ± 0.12 0.21 ± 0.22
4.0 ± 0.1 Citric 3.65 0.28 ± 0.06 2.78 ± 0.37 0.15 ± 0.04
Malic 4.55 0.24 ± 0.18 2.08 ± 0.32 0.10 ± 0.03
Lactic 8.00 0.27 ± 0.18 0.94 ± 0.28 0.15 ± 0.04
Benzoic 10.00 0.57 ± 0.58 1.11 ± 0.27 0.02 ± 0.03
Acetic 20.00 0.22 ± 0.08 0.42 ± 0.29 0.11 ± 0.10
For each specific pH, different concentrations of EDTA, citric, malic, lactic, benzoic, and acetic acid (given in mM) are used in combination with 2 µM of ABgp46 to reduce
E. coli O157:H7 cells in presence or absence of 5 mM of MgCl2. Averages ± standard deviations for all experiments are given for n = 4 repeats.Marked in bold are ≥1
log reduction units observed.
and acetic acid), reaching maximum activity at pH of 4.0. It is
known that some weak organic acids (e.g., citric, malic, benzoic,
and lactic acid) have, to a lesser extent, chelating properties,
but the additional acidity can also contribute to OM disruption
(Alakomi et al., 2000; Theron and Lues, 2011). LPS disintegration
is accomplished by the ability of undissociated acid groups
to interact/pass through the negatively charged LPS (whereas
negatively charged acid forms are repulsed) and migrate inside
the cells to cause sub-lethal injuries. Intracellularly, the organic
acid meets a higher internal pH (pH 7.2) and dissociates to
produce protons (that can exit through specific proton channels)
and anions (Breidt et al., 2004). Because the following bactericidal
decreasing effect was observed: citric acid (pKa 3.13) > malic
acid (pKa 3.4) > lactic acid (pKa 3.86) ≈ benzoic acid (pKa
4.19) > acetic acid (pKa 4.76) when combined with ABgp46, we
TABLE 3 | Combinatorial antibacterial activity of the best ABgp46/outer
membrane permeabilizers (EDTA, citric, and malic acid) formula against
broad range of planktonic Gram-negative pathogens.
Bacterial species ABgp46/EDTA ABgp46/citric ABgp46/malic
E coli O157:H7 0.32 ± 0.15 2.78 ± 0.37∗ 2.08 ± 0.32∗
A. baumannii #2 >5.00† >5.00† >5.00†
P. aeruginosa PAOI 4.35 ± 0.20 4.25 ± 0.31 4.51 ± 0.22
S. typhimurium LT2 0.57 ± 0.20 4.24 ± 0.39∗ 4.07 ± 0.37∗
C. sakazakii CECT 858 1.21 ± 0.38 2.05 ± 0.27 0.94 ± 0.23
K. oxytoca A1CC 13182 0.26 ± 0.08 0.96 ± 0.35∗ 0.81 ± 0.12∗
Averages ± standard deviations for all experiments are given for n = 4
repeats. Marked in bold are ≥1 log reduction units observed. Statistically
significantly (Student’s t-test and P < 0.05) conditions between ABgp46/EDTA
and ABgp46/organic acids are indicated with asteristic. †The detection level of
10 CFU/mL has been reached.
speculate that this it is a reflection of acid dissociation constant
(pKa) increase. This is somehow unexpected, since increasing
the pKa favors undissociated groups that could penetrate into
the cytoplasmic membrane potentiating cell damage. In contrast,
acids with low pKa values would produce more hydrogen ions
(that are not able to internalize) when exposed to an aqueous
environment. Nevertheless, a similar trend was observed when
organic acids (with lower pKa values) were incubated with
medium-chain fatty acids (Kim and Rhee, 2013). These authors
hypothesized that the medium-chain fatty acid action interact
with the bacterial cell membranes, causing sub-lethal injuries.
This would lead hydrogen ions to pass into the cell and result
in a marked bactericidal effect. Perhaps a similar mechanism
explains why ABgp46/citric acid and ABgp46/malic acid are
more powerful combinations compared to other OMPs. The
fact that no bacterial effect is observed in presence of 5 mM of
MgCl2, also suggests that free magnesium ions strengthen the
electrostatic interactions between neighboring LPS components,
avoiding acid entry and sequential sublethal damage (Vaara,
1999).
From preliminary testing, citric acid and malic acid were
chosen for further testing against a larger group of G− cells and
compared with EDTA. ABgp46/EDTA revealed to be the only
combination efficient against Pseudomonas and Acinetobacter
cells, the same pattern was previously observed with Lys68
(Oliveira et al., 2014). This can be explained by the high
phosphate content and consequently a higher concentration
of stabilizing divalent cations present in the OM of these
bacteria, compared with Enterobacteriaceae (such as E. coli and
S. typhimurium; Nikaido, 2003), that are therefore, more prone
to a chelation effect. The antibacterial effect of ABgp46 is more
broaden in the presence of organic acids that are predicted
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to destabilize the bacterial OM by an acidic effect, probably by
lowering the bacterial internal pH and the accumulation of toxic
substances (sub-lethal injury; Alakomi et al., 2000; Theron and
Lues, 2011).
In summary, the structural and enzymatic characterization
of ABgp46 provides novel insights into G−-like endolysins, and
indicated that ABgp46 is an effective endolysin against several
multidrug resistant pathogens. This technology can be appealing
as a therapeutic/disinfectant agent for a range of applications.
For instance, the use of topical solutions (e.g., cream or lotions)
containing the endolysin/OMP formula could be useful for
treating skin and soft tissue infections, associated with acne or
chronic wounds.
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